Craig Heim
Direktor/Vorstandsmitglied bei Colby Pharmaceutical Co.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
James Berbee | M | 60 |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Peter P. Tong | M | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
David A. Zarling | M | - |
Colby Pharmaceutical Co.
Colby Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Colby is transitioning to a clinical stage drug development company. The company was launched as a Wisconsin Alumni Research Foundation (WARF) spin-out and is strategically aligned with leading clinicians and drug discovery scientists at the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center (UWCCC). Colby is accessing data from funded grants and private investment to develop its therapeutic drugs for therapy-resistant and hypoxic conditions. Colby's lead drugs have unique mechanisms of action and target specific pathways. The company is focused on clinical development of its lead drugs, CPC-100 and -200, in patients with recurrent PCa and other solid tumors, respectively. In 2010, Colby plans to launch a Phase I/IIa study of CPC-100 in men with PCa who fail Androgen Depletion Therapy, as evidenced by rising PSA levels. CPC-200 is being scheduled for a Phase I/IIa in men with high-risk tumors. Colby's two pipeline drugs, CPC-300 and CPC-410 for therapy-resistant metastatic and hypoxic tumors are in late pre-clinical development and are funded by federal grants, including an awarded Colby SBIR grant and by private investors. The Company has demonstrated safety of its lead drugs following efficacy studies in rodents and toxicology studies in mice, rats, and dogs. | - |
Erik Iverson | M | 56 |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Michael Edward Falk | M | 57 |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | 17 Jahre |
John Gransee | M | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | 7 Jahre |
Juli Baumgartner | F | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | 17 Jahre |
Maureen Miner | F | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | 18 Jahre |
Laura Heisler | M | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | 20 Jahre |
Chris Haugen | M | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Devon Cournoyer | M | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Carol N. Skornicka | F | 82 |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
James Lester | M | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Jeffrey Spreen | M | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Leigh Cagan | M | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Deborah Keller | F | 61 |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Christopher Dinsmore | M | 58 |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Rebecca Blank | F | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Rebecca House | F | 51 |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Asha Collins | M | 48 |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | 1 Jahre |
Andrew Cohn | M | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Thomas Tefft | M | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | 1 Jahre |
James Thompson | M | 60 |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Joan Edelman Spero | M | 79 |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Anne K. Vallerga | M | - |
Colby Pharmaceutical Co.
Colby Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Colby is transitioning to a clinical stage drug development company. The company was launched as a Wisconsin Alumni Research Foundation (WARF) spin-out and is strategically aligned with leading clinicians and drug discovery scientists at the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center (UWCCC). Colby is accessing data from funded grants and private investment to develop its therapeutic drugs for therapy-resistant and hypoxic conditions. Colby's lead drugs have unique mechanisms of action and target specific pathways. The company is focused on clinical development of its lead drugs, CPC-100 and -200, in patients with recurrent PCa and other solid tumors, respectively. In 2010, Colby plans to launch a Phase I/IIa study of CPC-100 in men with PCa who fail Androgen Depletion Therapy, as evidenced by rising PSA levels. CPC-200 is being scheduled for a Phase I/IIa in men with high-risk tumors. Colby's two pipeline drugs, CPC-300 and CPC-410 for therapy-resistant metastatic and hypoxic tumors are in late pre-clinical development and are funded by federal grants, including an awarded Colby SBIR grant and by private investors. The Company has demonstrated safety of its lead drugs following efficacy studies in rodents and toxicology studies in mice, rats, and dogs. | - |
Minesh P. Mehta | M | 65 |
Colby Pharmaceutical Co.
Colby Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Colby is transitioning to a clinical stage drug development company. The company was launched as a Wisconsin Alumni Research Foundation (WARF) spin-out and is strategically aligned with leading clinicians and drug discovery scientists at the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center (UWCCC). Colby is accessing data from funded grants and private investment to develop its therapeutic drugs for therapy-resistant and hypoxic conditions. Colby's lead drugs have unique mechanisms of action and target specific pathways. The company is focused on clinical development of its lead drugs, CPC-100 and -200, in patients with recurrent PCa and other solid tumors, respectively. In 2010, Colby plans to launch a Phase I/IIa study of CPC-100 in men with PCa who fail Androgen Depletion Therapy, as evidenced by rising PSA levels. CPC-200 is being scheduled for a Phase I/IIa in men with high-risk tumors. Colby's two pipeline drugs, CPC-300 and CPC-410 for therapy-resistant metastatic and hypoxic tumors are in late pre-clinical development and are funded by federal grants, including an awarded Colby SBIR grant and by private investors. The Company has demonstrated safety of its lead drugs following efficacy studies in rodents and toxicology studies in mice, rats, and dogs. | - |
David Smukowski | M | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Richard Zare | M | - |
Colby Pharmaceutical Co.
Colby Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Colby is transitioning to a clinical stage drug development company. The company was launched as a Wisconsin Alumni Research Foundation (WARF) spin-out and is strategically aligned with leading clinicians and drug discovery scientists at the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center (UWCCC). Colby is accessing data from funded grants and private investment to develop its therapeutic drugs for therapy-resistant and hypoxic conditions. Colby's lead drugs have unique mechanisms of action and target specific pathways. The company is focused on clinical development of its lead drugs, CPC-100 and -200, in patients with recurrent PCa and other solid tumors, respectively. In 2010, Colby plans to launch a Phase I/IIa study of CPC-100 in men with PCa who fail Androgen Depletion Therapy, as evidenced by rising PSA levels. CPC-200 is being scheduled for a Phase I/IIa in men with high-risk tumors. Colby's two pipeline drugs, CPC-300 and CPC-410 for therapy-resistant metastatic and hypoxic tumors are in late pre-clinical development and are funded by federal grants, including an awarded Colby SBIR grant and by private investors. The Company has demonstrated safety of its lead drugs following efficacy studies in rodents and toxicology studies in mice, rats, and dogs. | - |
Winslow Sargeant | M | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | 9 Jahre |
Doris Meissner | F | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Jeffrey Sprecher | M | 69 |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Paul Leff | M | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | 1 Jahre |
Patricia Lipton | F | - |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Thomas F. Pyle | M | 82 |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
John Morgridge | M | 91 |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Norman R. Bobins | M | 81 |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Gordon F. Brunner | M | 85 |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Wisconsin Alumni Research Foundation provides research patenting and licensing services. It helps steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin. The firm provides its support services for the entire cycle of innovation, from research to invention to investment. The company was founded in 1925 and is headquartered in Madison, WI. | - |
Bruce Fieldman | M | - |
Colby Pharmaceutical Co.
Colby Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Colby is transitioning to a clinical stage drug development company. The company was launched as a Wisconsin Alumni Research Foundation (WARF) spin-out and is strategically aligned with leading clinicians and drug discovery scientists at the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center (UWCCC). Colby is accessing data from funded grants and private investment to develop its therapeutic drugs for therapy-resistant and hypoxic conditions. Colby's lead drugs have unique mechanisms of action and target specific pathways. The company is focused on clinical development of its lead drugs, CPC-100 and -200, in patients with recurrent PCa and other solid tumors, respectively. In 2010, Colby plans to launch a Phase I/IIa study of CPC-100 in men with PCa who fail Androgen Depletion Therapy, as evidenced by rising PSA levels. CPC-200 is being scheduled for a Phase I/IIa in men with high-risk tumors. Colby's two pipeline drugs, CPC-300 and CPC-410 for therapy-resistant metastatic and hypoxic tumors are in late pre-clinical development and are funded by federal grants, including an awarded Colby SBIR grant and by private investors. The Company has demonstrated safety of its lead drugs following efficacy studies in rodents and toxicology studies in mice, rats, and dogs. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 38 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Craig Heim
- Persönliches Netzwerk